Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles
- PMID: 7092178
- DOI: 10.1002/ana.410110305
Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles
Abstract
Progressively increasing concentrations of potassium chloride in Evans blue saline were administered to patients affected with myotonic dystrophy and to healthy volunteers before and after parenteral treatment with taurine. Excitability changes of thenar eminence muscles were related to the venous potassium and chloride concentrations. The actual electrolyte concentrations were compared to those to be expected if no infused electrolytes had been transported into cells. The expected concentrations were calculated by means of Evans blue dilution. This method permitted quantification of changes of muscle-excitability in terms of the potassium chloride concentration capable of disturbing the electrical activity of the studied muscles. The method also provided an indirect evaluation of electrolyte movements across muscle membrane in vivo in humans. Dystrophic myotonic muscles appeared highly sensitive to extracellular potassium and, unlike normal muscles, were unable to accumulate potassium-induced muscle hyperexcitability and favored electrolyte accumulation in dystrophic myotonic muscles. The stabilizing effect of taurine is discussed in relation to its ability to increase intracellular potassium concentration, membrane conductance, or both.
Similar articles
-
The effects of the increase of arterial potassium upon the excitability of normal and dystrophic myotonic muscles in man.J Neurol Sci. 1982 Sep;55(3):249-57. doi: 10.1016/0022-510x(82)90123-x. J Neurol Sci. 1982. PMID: 7131034
-
Myotonia, potassium and taurine. A preliminary report.J Neurol Sci. 1979 Jun;42(1):103-9. doi: 10.1016/0022-510x(79)90155-2. J Neurol Sci. 1979. PMID: 448391
-
Normalization of muscle transmembrane ionic fluxes induced by taurine in patients affected with myotonic dystrophy.Acta Neurol Belg. 1982 May-Jun;82(3):122-7. Acta Neurol Belg. 1982. PMID: 6287791 No abstract available.
-
A mechanistic approach to the myotonic syndromes.Muscle Nerve. 1982;5(9S):S60-3. Muscle Nerve. 1982. PMID: 6763150 Review.
-
[Chloride conductance and permeability in the mammalian straited muscle].Bol Estud Med Biol. 1974;Suppl 1:59-66. Bol Estud Med Biol. 1974. PMID: 4619019 Review. Spanish. No abstract available.
Cited by
-
Drug treatment for myotonia.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004762. doi: 10.1002/14651858.CD004762.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2025 Apr 08;4:CD004762. doi: 10.1002/14651858.CD004762.pub3. PMID: 16437496 Free PMC article. Updated.
-
Taurine: the appeal of a safe amino acid for skeletal muscle disorders.J Transl Med. 2015 Jul 25;13:243. doi: 10.1186/s12967-015-0610-1. J Transl Med. 2015. PMID: 26208967 Free PMC article. Review.
-
Drug treatment for myotonia.Cochrane Database Syst Rev. 2025 Apr 8;4(4):CD004762. doi: 10.1002/14651858.CD004762.pub3. Cochrane Database Syst Rev. 2025. PMID: 40197813
-
Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis.Neurol Sci. 2024 Aug;45(8):3989-4001. doi: 10.1007/s10072-024-07412-z. Epub 2024 Feb 26. Neurol Sci. 2024. PMID: 38403671
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources